HN
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.284
Exchange
XSTO - Nasdaq STOCKHOLM AB
2.9
Last period Current ratio
-78%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Hansa Biopharma
Company Analysis
HNSA.ST valuation, rating, competitors, insights and company profile
Eyestock Rating
HNSA.ST financial analysis by Eyestock methodology
Valuation
HNSA.ST valuation using historical relative method
Statements
HNSA.ST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
HNSA.ST dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Hansa Biopharma`s Current ratio for the last twelve months ended 2024-06-30 is 2.9
